MetaCap

Royalty Pharma Statistics

NASDAQ: RPRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

68.45+0.73 (+1.08%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Royalty Pharma by the numbers

Royalty Pharma has a market capitalization of $39.36 billion based on 445.27M shares outstanding. Its trailing P/E ratio is 44.7, above the 5-company peer median of 43.2, and its forward P/E is 11.6. The stock trades 9.9% above its 50-day average and 23.9% above its 200-day average.

Average daily trading volume is 3.21M shares, or about $220.0 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

RPRX valuation vs. peer median

RPRX compared with the median of 8 peer companies
MetricRPRXPeer medianDifference
Market cap$39.36B$31.10B+27%
P/E (TTM)44.743.2+3%
Forward P/E11.617.4-33%
Avg. volume3.21M4.34M-26%

Peer median across 8 companies: ONC, ZTS, TEVA, GMAB, INSM, ROIV, UTHR, VTRS.

Valuation

Market cap
$39.36B
Price / sales (latest FY)
16.55

Price and trading

Previous close
67.72
Open
68.17
Day range
67.95 – 68.83
52-week range
37.31 – 70.37
52-week change
+75.87%
Beta
—
Volume
3.53M

Dividends and events

Annual dividend
$0.925

Additional statistics

Market Cap
39.36B
Pe
44.74
Forward Pe
11.62
Eps
1.53
Dividend Yield
137.00%
Dividend Rate
0.93
Week52 High
70.37
Week52 Low
37.31
Avg Volume
3.21M
Shares Outstanding
445.27M
Ma50
62.31
Ma200
55.26
Earnings Date
Nov 4, 2026
Pct From52w High
-2.73%
Pct From52w Low
83.46%

Related